Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Mallinckrodt
Dow
Johnson and Johnson
Baxter
Teva
Boehringer Ingelheim
Queensland Health
Healthtrust

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,567,817

« Back to Dashboard

Summary for Patent: 5,567,817

Title: Triazole antifungal agents
Abstract:The invention provides antifungal compounds of the formula: ##STR1## and pharmaceutical salts thereof, wherein R is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; X is CH or N; and Y is F or Cl.
Inventor(s): Ray; Stephen J. (Deal, GB2), Richardson; Kenneth (Birchington;, GB2)
Assignee: Pfizer Inc. (New York, NY)
Application Number:08/432,414
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,567,817

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9002375Feb 02, 1990

International Patent Family for Patent: 5,567,817

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland64774► Subscribe
Ireland910342► Subscribe
Hungary211582► Subscribe
Hungary205351► Subscribe
Israel110322► Subscribe
Israel97045► Subscribe
Finland910508► Subscribe
Spain2055523► Subscribe
European Patent Office0440372► SubscribeSPC/GB02/031United Kingdom► Subscribe
European Patent Office0440372► Subscribe90960Luxembourg► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
Julphar
Novartis
Queensland Health
Deloitte
Express Scripts
US Department of Justice
McKinsey
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot